Back to News & Events
Clint Rubin inducted into Stony Brook’s National Academy of Inventors
April 11, 2016
On Monday, April 11, 2016 Stony Brook University launched its chapter of the National Academy of Inventors. With the launch, 30 university of faculty members will be inducted into that chapter’s Hall of Fame, including Center for Biotechnology Director and Biomedical Engineering Chair, Dr. Clinton Rubin.
The NAI was founded in 2010 at the University of South Florida to recognize and encourage inventors who earn U.S. patents. The organization aims to enhance the visibility of university-based innovations and promote the societal benefits of technological and academic breakthroughs. Stony Brook joins more than 200 other NAI chapter members around the globe that will “foster research that leads to academic inventions and entrepreneurship from faculty and students,” while building “a culture of invention across all campus disciplines,” SBU said in a statement. A full list of first inductees can be found here.
Related Stories
WP_Query Object
(
[query] => Array
(
[post_type] => post
[posts_per_page] => 3
[post_status] => publish
[orderby] => rand
)
[query_vars] => Array
(
[post_type] => post
[posts_per_page] => 3
[post_status] => publish
[orderby] => rand
[error] =>
[m] =>
[p] => 0
[post_parent] =>
[subpost] =>
[subpost_id] =>
[attachment] =>
[attachment_id] => 0
[name] =>
[pagename] =>
[page_id] => 0
[second] =>
[minute] =>
[hour] =>
[day] => 0
[monthnum] => 0
[year] => 0
[w] => 0
[category_name] =>
[tag] =>
[cat] =>
[tag_id] =>
[author] =>
[author_name] =>
[feed] =>
[tb] =>
[paged] => 0
[meta_key] =>
[meta_value] =>
[preview] =>
[s] =>
[sentence] =>
[title] =>
[fields] => all
[menu_order] =>
[embed] =>
[category__in] => Array
(
)
[category__not_in] => Array
(
)
[category__and] => Array
(
)
[post__in] => Array
(
)
[post__not_in] => Array
(
)
[post_name__in] => Array
(
)
[tag__in] => Array
(
)
[tag__not_in] => Array
(
)
[tag__and] => Array
(
)
[tag_slug__in] => Array
(
)
[tag_slug__and] => Array
(
)
[post_parent__in] => Array
(
)
[post_parent__not_in] => Array
(
)
[author__in] => Array
(
)
[author__not_in] => Array
(
)
[search_columns] => Array
(
)
[ignore_sticky_posts] =>
[suppress_filters] =>
[cache_results] => 1
[update_post_term_cache] => 1
[update_menu_item_cache] =>
[lazy_load_term_meta] => 1
[update_post_meta_cache] => 1
[nopaging] =>
[comments_per_page] => 50
[no_found_rows] =>
[order] =>
)
[tax_query] => WP_Tax_Query Object
(
[queries] => Array
(
)
[relation] => AND
[table_aliases:protected] => Array
(
)
[queried_terms] => Array
(
)
[primary_table] => wp_posts
[primary_id_column] => ID
)
[meta_query] => WP_Meta_Query Object
(
[queries] => Array
(
)
[relation] =>
[meta_table] =>
[meta_id_column] =>
[primary_table] =>
[primary_id_column] =>
[table_aliases:protected] => Array
(
)
[clauses:protected] => Array
(
)
[has_or_relation:protected] =>
)
[date_query] =>
[request] => SELECT SQL_CALC_FOUND_ROWS wp_posts.ID
FROM wp_posts
WHERE 1=1 AND wp_posts.post_type = 'post' AND ((wp_posts.post_status = 'publish'))
ORDER BY RAND()
LIMIT 0, 3
[posts] => Array
(
[0] => WP_Post Object
(
[ID] => 2045
[post_author] => 3
[post_date] => 2016-02-10 19:43:41
[post_date_gmt] => 2016-02-10 19:43:41
[post_content] => Celmatix has announced a collaboration with 23andMe, the leading personal genetics company, with the goal of improving infertility outcomes. This collaboration will accelerate the launch of Celmatix’s tests, which will aim to provide physicians with a comprehensive genetic lens on infertility. This will also enable the development of early screening tests which will help OBGYNs identify women who are at risk for premature decline of their ovarian function, which has both infertility and broader health implications. Read the announcement here.
[post_title] => Celmatix to Partner with 23andMe
[post_excerpt] =>
[post_status] => publish
[comment_status] => open
[ping_status] => open
[post_password] =>
[post_name] => 2045-2
[to_ping] =>
[pinged] =>
[post_modified] => 2016-03-29 19:45:50
[post_modified_gmt] => 2016-03-29 19:45:50
[post_content_filtered] =>
[post_parent] => 0
[guid] => http://centerforbiotechnology.org/?p=2045
[menu_order] => 191
[post_type] => post
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[1] => WP_Post Object
(
[ID] => 2043
[post_author] => 3
[post_date] => 2016-02-18 19:40:38
[post_date_gmt] => 2016-02-18 19:40:38
[post_content] => Piraye Yurttas Beim, co-founder and CEO of Celmatix was named to “The Fortune Entrepreneurs List”. Celmatix's technology enabled products analyze big data and genomics to optimize the treatment of infertility and allow for proactive fertility management. Read the feature on Dr. Beim on Fortune.com.
[post_title] => Celmatix CEO Named to Fortune’s Entrepreneurs List
[post_excerpt] =>
[post_status] => publish
[comment_status] => open
[ping_status] => open
[post_password] =>
[post_name] => celmatix-ceo-named-to-fortunes-entrepreneurs-list
[to_ping] =>
[pinged] =>
[post_modified] => 2016-03-29 19:42:38
[post_modified_gmt] => 2016-03-29 19:42:38
[post_content_filtered] =>
[post_parent] => 0
[guid] => http://centerforbiotechnology.org/?p=2043
[menu_order] => 190
[post_type] => post
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[2] => WP_Post Object
(
[ID] => 3020
[post_author] => 3
[post_date] => 2018-08-13 15:28:55
[post_date_gmt] => 2018-08-13 15:28:55
[post_content] => The Gund-Harrington Initiative for Fighting Blindness announces the call for proposals for the 2019 Gund-Harrington Scholar Award.
The Gund-Harrington Scholar Award supports innovative research efforts that could prevent, treat or cure blindness resulting from inherited retinal degenerative diseases. The Gund-Harrington Scholar Award is part of the Gund-Harrington Initiative for Fighting Blindness and sponsored by Foundation Fighting Blindness and Harrington Discovery Institute.
Who should apply?
- U.S and Canadian scientists at accredited academic medical centers, research institutions and universities whose discoveries show promise for translation into novel treatments for inherited retinal degenerative diseases.
- Multidisciplinary investigators outside the field of retinal disease developing a therapeutic strategy with a potential to benefit inherited retinal degenerative diseases are particularly encouraged to apply.
Multi-Level Support for Award Recipients includes:
- Funding totaling up to $900,000 over three years based on progress made towards milestones
- Drug development and project management support
- Dedicated pharma team for each scholar
- Clinical development strategy
- Regulatory guidance
Letters of Intent are now being accepted through midnight on October 12, 2018.
Apply Here.
[post_title] => Funding Opportunity: Gund-Harrington Scholar Award for Fighting Blindness
[post_excerpt] =>
[post_status] => publish
[comment_status] => open
[ping_status] => open
[post_password] =>
[post_name] => funding-opportunity-gund-harrington-scholar-award-for-fighting-blindness
[to_ping] =>
[pinged] =>
[post_modified] => 2018-08-13 15:28:55
[post_modified_gmt] => 2018-08-13 15:28:55
[post_content_filtered] =>
[post_parent] => 0
[guid] => http://centerforbiotechnology.org/?p=3020
[menu_order] => 116
[post_type] => post
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
)
[post_count] => 3
[current_post] => -1
[before_loop] => 1
[in_the_loop] =>
[post] => WP_Post Object
(
[ID] => 2045
[post_author] => 3
[post_date] => 2016-02-10 19:43:41
[post_date_gmt] => 2016-02-10 19:43:41
[post_content] =>
Celmatix has announced a collaboration with
23andMe, the leading personal genetics company, with the goal of improving infertility outcomes. This collaboration will accelerate the launch of Celmatix’s tests, which will aim to provide physicians with a comprehensive genetic lens on infertility. This will also enable the development of early screening tests which will help OBGYNs identify women who are at risk for premature decline of their ovarian function, which has both infertility and broader health implications. Read the announcement
here.
[post_title] => Celmatix to Partner with 23andMe
[post_excerpt] =>
[post_status] => publish
[comment_status] => open
[ping_status] => open
[post_password] =>
[post_name] => 2045-2
[to_ping] =>
[pinged] =>
[post_modified] => 2016-03-29 19:45:50
[post_modified_gmt] => 2016-03-29 19:45:50
[post_content_filtered] =>
[post_parent] => 0
[guid] => http://centerforbiotechnology.org/?p=2045
[menu_order] => 191
[post_type] => post
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[comment_count] => 0
[current_comment] => -1
[found_posts] => 282
[max_num_pages] => 94
[max_num_comment_pages] => 0
[is_single] =>
[is_preview] =>
[is_page] =>
[is_archive] =>
[is_date] =>
[is_year] =>
[is_month] =>
[is_day] =>
[is_time] =>
[is_author] =>
[is_category] =>
[is_tag] =>
[is_tax] =>
[is_search] =>
[is_feed] =>
[is_comment_feed] =>
[is_trackback] =>
[is_home] => 1
[is_privacy_policy] =>
[is_404] =>
[is_embed] =>
[is_paged] =>
[is_admin] =>
[is_attachment] =>
[is_singular] =>
[is_robots] =>
[is_favicon] =>
[is_posts_page] =>
[is_post_type_archive] =>
[query_vars_hash:WP_Query:private] => 325c4f9f1aebaa5ec90666fa54175ba0
[query_vars_changed:WP_Query:private] =>
[thumbnails_cached] =>
[allow_query_attachment_by_filename:protected] =>
[stopwords:WP_Query:private] =>
[compat_fields:WP_Query:private] => Array
(
[0] => query_vars_hash
[1] => query_vars_changed
)
[compat_methods:WP_Query:private] => Array
(
[0] => init_query_flags
[1] => parse_tax_query
)
[query_cache_key:WP_Query:private] =>
)
February 10, 2016
More Information
February 18, 2016
More Information
August 13, 2018
More Information